Biochemical Pharmacology Discussion Group
The New York Academy of Sciences
Help the New York Academy of Sciences bring late-breaking scientific information about the COVID-19 pandemic to global audiences. Please make a tax-deductible gift today.
DONATEPosted May 29, 2019
Despite intense research following the first isolation of embryonic stem cells in 1981, few viable stem cell-based therapies have emerged in the last 30 years. More recently, researchers have made significant progress in uncovering how stem cell activation and differentiation are regulated by signals from the stem cell niche and modulated by intrinsic epigenetic changes. These studies have also revealed how these processes can go awry in aging and disease states, leading to potential therapeutic strategies to target endogenous stem cells or improve the efficacy of stem cell transplantation.
Learn more about recent breakthroughs in stem cell research and the implications for treating an array of diseases—including various cancers and age-related tissue dysfunction—in this summary of our March 14, 2019 symposium.